Please wait while the formulary information is being retrieved.
AURYXIA (FERRIC CITRATE)
- Anemia in non-dialysis-dependent chronic kidney disease
- Renal osteodystrophy with hyperphosphatemia
210 mg iron tablet
- 2 tablets (420 mg) by oral route 3 times per day
210 mg iron tablet
- 2 tablets (420 mg) by oral route 3 times per day
Anemia in non-dialysis-dependent chronic kidney disease
- 1 tablet (210 mg) by oral route 3 times per day
- 2 tablets (420 mg) by oral route 3 times per day
- 3 tablets (630 mg) by oral route 3 times per day
- 4 tablets (840 mg) by oral route 3 times per day
Renal osteodystrophy with hyperphosphatemia
- 2 tablets (420 mg) by oral route 3 times per day
- 3 tablets (630 mg) by oral route 3 times per day
- 4 tablets (840 mg) by oral route 3 times per day
- None
Contraindicated
- Adoxa
- Avidoxy
- carbidopa-levodopa
- carbidopa-levodopa-entacapone
- demeclocycline
- Doryx
- doxycycline calcium
- doxycycline hyclate
- doxycycline monohydrate
- Minocin
- minocycline
- Monodox
- Morgidox
- Oracea
- Sinemet
- Sinemet Cr
- Solodyn
- Stalevo 100
- Stalevo 125
- Stalevo 150
- Stalevo 200
- Stalevo 50
- Stalevo 75
- tetracycline
- Vibramycin
Severe
Moderate
- Actonel
- alendronate
- Armour Thyroid
- Atelvia
- Avelox
- Avelox Abc Pack
- Boniva
- cefdinir
- Cipro
- Cipro Xr
- ciprofloxacin
- ciprofloxacin (mixture)
- Cuprimine
- Cytomel
- deferiprone
- Depen Titratabs
- dolutegravir
- eltrombopag
- etidronate disodium
- Ferriprox
- Fosamax
- Fosamax Plus D
- ibandronate
- Levaquin
- levofloxacin
- levothyroxine
- Levoxyl
- liothyronine
- liotrix
- methyldopa
- methyldopa-hydrochlorothiazide
- moxifloxacin
- Nature-throid
- norfloxacin
- Noroxin
- Np Thyroid
- ofloxacin
- penicillamine
- Promacta
- risedronate
- Synthroid
- thyroid (pork)
- Thyrolar-1
- Thyrolar-1/2
- Thyrolar-1/4
- Thyrolar-2
- Thyrolar-3
- Tirosint
- Tivicay
- Unithroid
- Westhroid
- Wp Thyroid
- Hemochromatosis
Contraindicated
- Chronic iron overload due to repeated blood transfusions
- Diverticular disease
- Gastritis
- Hemolytic anemia
- Hemosiderosis
- Ulcerative colitis
Severe
Moderate
- Peptic ulcer
AURYXIA (FERRIC CITRATE)
- Anemia in non-dialysis-dependent chronic kidney disease
- Renal osteodystrophy with hyperphosphatemia
- None
- Diarrhea
- Nausea
More Frequent
Severe
Less Severe
- Hyperkalemia
- Acute abdominal pain
- Black stools
- Constipation
- Cough
- Vomiting
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- None
Less Severe
- None
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Ferric Citrate
Safety and efficacy not established.
- 1 Day – 18 Years
- Safety and efficacy not established.
Ferric Citrate (phosphate Binding)
- Severity Level:
2
- Additional Notes: Insuff data avail, assess maternal treatment benefit vs pot fetal risks
Contraindicated
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Precaution Exists
Ferric Citrate (phosphate Binding)
Iron transport into milk occurs in rat studies.
General | Excretion Potential | Effect on Infant | Notes |
Evaluate use carefully | Unknown | Not known; no or inclusive data | Iron transport into milk occurs in rat studies. |
No Known Risk
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
Anemia in non-dialysis-dependent chronic kidney disease | |
D63.1 | Anemia in chronic kidney disease |
Renal osteodystrophy with hyperphosphatemia | |
N25.0 | Renal osteodystrophy |
0-9 | A-Z |
---|---|
D63.1 | Anemia in chronic kidney disease |
N25.0 | Renal osteodystrophy |
Formulary Reference Tool